| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 2905 |
| 1 | INTERFERON BETA-1A | 2197 |
| 2 | NATALIZUMAB | 1673 |
| 3 | DIMETHYL FUMARATE | 1364 |
| 4 | ERGOCALCIFEROL | 731 |
| 5 | DALFAMPRIDINE | 726 |
| 6 | GLATIRAMER ACETATE | 638 |
| 7 | GABAPENTIN | 571 |
| 8 | BACLOFEN | 473 |
| 9 | TERIFLUNOMIDE | 378 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FINGOLIMOD HCL | 2905 | 0.0337 |
| 1 | ERGOCALCIFEROL | 731 | 0.0246 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 98 | 0.0192 |
| 3 | SIPONIMOD | 107 | 0.0120 |
| 4 | INTERFERON BETA-1A | 2197 | 0.0114 |
| 5 | GLATIRAMER ACETATE | 638 | 0.0107 |
| 6 | DALFAMPRIDINE | 726 | 0.0101 |
| 7 | NATALIZUMAB | 1673 | 0.0092 |
| 8 | DIROXIMEL FUMARATE | 109 | 0.0090 |
| 9 | TERIFLUNOMIDE | 378 | 0.0084 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 2289 |
| 1 | Integrin Receptor Antagonist [EPC] | 1698 |
| 2 | Corticosteroid [EPC] | 926 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 855 |
| 4 | Benzodiazepine [EPC] | 767 |
| 5 | Provitamin D2 Compound [EPC] | 731 |
| 6 | Potassium Channel Blocker [EPC] | 726 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 552 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 473 |
| 9 | Kinase Inhibitor [EPC] | 452 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 731 | 0.0246 |
| 1 | Integrin Receptor Antagonist [EPC] | 1698 | 0.0195 |
| 2 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 193 | 0.0139 |
| 3 | Interferon beta [EPC] | 2289 | 0.0119 |
| 4 | Potassium Channel Blocker [EPC] | 726 | 0.0101 |
| 5 | Pyrimidine Synthesis Inhibitor [EPC] | 378 | 0.0084 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 118 | 0.0061 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 76 | 0.0059 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 473 | 0.0053 |
| 9 | Sympathomimetic-like Agent [EPC] | 101 | 0.0031 |